Identification of a novel series of benzimidazoles as potent and selective antagonists of the human melanocortin-4 receptor.
A novel series of benzimidazoles was identified and optimized, leading to the discovery of potent and selective antagonists of the human melanocortin-4 receptor. In addition, compound 5i was shown to cross the blood-brain barrier after intravenous dosing in rats.